Nikkei Asia · General

Global pharma firms walk back innovative drug investments in Japan

· By Staff Writer
Story summary

35% of investment plans face downsizing or possible relocation, poll finds

Read at Nikkei Asia

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.